Celularity and Fountain Life Stem Cell Investigation

In July 2025, Celularity Inc., a New Jersey biotechnology company, announced a partnership to supply stem cell therapy products to Fountain Life, a longevity clinic network. Five months later, on December 1, 2025, the FDA sent Celularity a warning letter. The Lyon Firm is now investigating consumer concerns about stem cell marketing connected to these companies. Contact our consumer fraud attorneys to learn more and to weigh your legal options.

What the FDA Letter Says

The letter addresses Interfyl, a placental connective tissue matrix that Celularity manufactures and Arthrex distributes for orthopedic surgery. The FDA wrote that Interfyl is an unapproved new drug and an unlicensed biological product, based on how it was promoted for tendon injuries, inflammation and wound healing.

The warning letter does not mention Fountain Life or the stem cell products Celularity said it would supply. In a securities filing, Celularity said it takes the matters seriously and plans to work with the FDA. The company also said the letter does not restrict its ability to manufacture or ship products.

The Fountain Life Partnership

Celularity’s announcement said Fountain Life would offer therapies under a Florida law that took effect July 1, 2025. That law lets licensed physicians use certain stem cell products for orthopedics, wound care and pain management without an investigational new drug approval.

Although Fountain Life’s website states that stem cell therapy is not FDA approved and encourages members to consult their primary care provider, there have been consumer questions about misleading advertising in the industry. The site lists centers in Dallas, New York, Orlando, Naples and Houston, with Miami and Los Angeles coming soon. It says stem cell therapies are available at selected centers.

Did You Pay for Stem Cell Therapy?

If you bought a stem cell treatment through Fountain Life or another clinic that used Celularity products, we want to hear from you. Save your receipts, membership agreements, consent forms and any ads or emails. Call The Lyon Firm at (513) 381-2333 or request a free, confidential case review.

Common Stem Cell Fraud Claims

Consumer lawsuits over stem cell treatments often center on a few themes:

• Marketing that suggests a therapy can reverse aging or heal serious conditions
• Unclear disclosure of FDA status, product sourcing and risks
• Membership or package fees that bundle therapies with limited results
• Infections, reactions or other complications after treatment

These are general categories, not allegations against any company named here. We are not accusing Celularity, Fountain Life or any clinic of wrongdoing. Our investigation examines consumer concerns and public FDA statements.

Why Choose The Lyon Firm

The Lyon Firm represents consumers in stem cell fraud and deceptive marketing cases. Over 23 years, attorney Joseph Lyon has handled consumer class actions and mass torts across all fifty states. Courts frequently appoint the firm to leadership roles, and its work has helped secure relief for more than 50 million class members.

The firm has recovered more than $550 million for clients and class members. If you believe you have a valid claim, call us for a consult or to learn more about the legal process.

The Lyon Firm is investigating consumer concerns and has not concluded that Celularity, Inc., Fountain Life or any affiliated clinic violated any law. Statements attributed to the FDA, Celularity and Fountain Life come from public documents and company websites.